Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries
The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/9/2531 |
id |
doaj-00ea29ec477e4a30934c9213ea060108 |
---|---|
record_format |
Article |
spelling |
doaj-00ea29ec477e4a30934c9213ea0601082020-11-25T03:52:41ZengMDPI AGNutrients2072-66432020-08-01122531253110.3390/nu12092531Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European CountriesAlexander Kriz0Antony Wright1Mattias Paulsson2Stephen Tomlin3Venetia Simchowitz4Thibault Senterre5Julian Shepelev6Executive Insight AG, 8008 Zurich, SwitzerlandMaverex Ltd., Newcastle upon Tyne NE6 2HL, UKDepartment of Women’s and Children’s Health, Uppsala University, 751 85 Uppsala, SwedenGreat Ormond Street Hospital, London WC1N 3JH, UKGreat Ormond Street Hospital, London WC1N 3JH, UKDepartment of Neonatology, Liège University, 4000 Liège, BelgiumBaxter Healthcare Ltd., Compton RG20 7QW, UKThe safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on clinical outcomes, healthcare resources, and hospital budgets across seven European countries. A ten-percentage-point 3CB use-increase model was developed for Belgium, France, Germany, Italy, Portugal, Spain, and the UK. The cost-consequence analysis estimated the impact on compounding error harm and bloodstream infection (BSI) rates, staff time, and annual hospital budget. Of 265,000 (52%) preterm neonates, 133,000 (52%) were estimated to require PN. Baseline compounding methods were estimated as 43% pharmacy manual, 16% pharmacy automated, 22% ward, 9% outsourced, 3% industry provided non-3CBs, and 7% 3CBs. A modeled increased 3CB use would change these values to 39%, 15%, 18%, 9%, 3%, and 17%, respectively. Modeled consequences included −11.6% for harm due to compounding errors and −2.7% for BSIs. Labor time saved would equate to 41 specialized nurses, 29 senior pharmacists, 26 pharmacy assistants, and 22 senior pediatricians working full time. Budget impact would be a €8,960,601 (3.4%) fall from €260,329,814 to €251,369,212. Even a small increase in the use of 3CBs in preterm neonates could substantially improve neonatal clinical outcomes, and provide notable resource and cost savings to hospitals.https://www.mdpi.com/2072-6643/12/9/2531preterm neonatescompounding errorsparenteral nutritionready-to-use three-chamber-bagscost-consequence analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Alexander Kriz Antony Wright Mattias Paulsson Stephen Tomlin Venetia Simchowitz Thibault Senterre Julian Shepelev |
spellingShingle |
Alexander Kriz Antony Wright Mattias Paulsson Stephen Tomlin Venetia Simchowitz Thibault Senterre Julian Shepelev Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries Nutrients preterm neonates compounding errors parenteral nutrition ready-to-use three-chamber-bags cost-consequence analysis |
author_facet |
Alexander Kriz Antony Wright Mattias Paulsson Stephen Tomlin Venetia Simchowitz Thibault Senterre Julian Shepelev |
author_sort |
Alexander Kriz |
title |
Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries |
title_short |
Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries |
title_full |
Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries |
title_fullStr |
Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries |
title_full_unstemmed |
Cost-Consequences Analysis of Increased Utilization of Triple-Chamber-Bag Parenteral Nutrition in Preterm Neonates in Seven European Countries |
title_sort |
cost-consequences analysis of increased utilization of triple-chamber-bag parenteral nutrition in preterm neonates in seven european countries |
publisher |
MDPI AG |
series |
Nutrients |
issn |
2072-6643 |
publishDate |
2020-08-01 |
description |
The safety of parenteral nutrition (PN) remains a concern in preterm neonates, impacting clinical outcomes and health-care-resource use and costs. This cost-consequence analysis assessed national-level impacts of a 10-percentage point increase in use of industry-prepared three-chamber bags (3CBs) on clinical outcomes, healthcare resources, and hospital budgets across seven European countries. A ten-percentage-point 3CB use-increase model was developed for Belgium, France, Germany, Italy, Portugal, Spain, and the UK. The cost-consequence analysis estimated the impact on compounding error harm and bloodstream infection (BSI) rates, staff time, and annual hospital budget. Of 265,000 (52%) preterm neonates, 133,000 (52%) were estimated to require PN. Baseline compounding methods were estimated as 43% pharmacy manual, 16% pharmacy automated, 22% ward, 9% outsourced, 3% industry provided non-3CBs, and 7% 3CBs. A modeled increased 3CB use would change these values to 39%, 15%, 18%, 9%, 3%, and 17%, respectively. Modeled consequences included −11.6% for harm due to compounding errors and −2.7% for BSIs. Labor time saved would equate to 41 specialized nurses, 29 senior pharmacists, 26 pharmacy assistants, and 22 senior pediatricians working full time. Budget impact would be a €8,960,601 (3.4%) fall from €260,329,814 to €251,369,212. Even a small increase in the use of 3CBs in preterm neonates could substantially improve neonatal clinical outcomes, and provide notable resource and cost savings to hospitals. |
topic |
preterm neonates compounding errors parenteral nutrition ready-to-use three-chamber-bags cost-consequence analysis |
url |
https://www.mdpi.com/2072-6643/12/9/2531 |
work_keys_str_mv |
AT alexanderkriz costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries AT antonywright costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries AT mattiaspaulsson costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries AT stephentomlin costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries AT venetiasimchowitz costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries AT thibaultsenterre costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries AT julianshepelev costconsequencesanalysisofincreasedutilizationoftriplechamberbagparenteralnutritioninpretermneonatesinseveneuropeancountries |
_version_ |
1724481499201273856 |